- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.12.24 | Coherus sells its last biosimilar Udenyca to Intas for up to $558M as company homes in on novel cancer meds | ||
| 03.12.24 | IRA price negotiations and M&A among topics to watch after 'Republican Red Wave,' analyst group says | ||
| 03.12.24 | CSL Seqirus inks bird flu vaccine supply pact with UK after similar deals in US, Europe | ||
| 03.12.24 | Reckitt shells out $200M to expand its Mucinex production site in North Carolina | ||
| 03.12.24 | Lil Jon delivers scat rap, duets with singing toilet to promote Exact Sciences' cancer kit | ||
| 03.12.24 | Agenus to offer CDMO services as part of its latest reorganization | ||
| 03.12.24 | RFK Jr. could 'cost lives in this country' if he pursues changes to US vaccine policy, Gottlieb says | ||
| 02.12.24 | After temporary reprieve, Advanz Pharma's liver med Ocaliva loses marketing nod in Europe | ||
| 02.12.24 | Quantoom, Univercells and Fiocruz ink collaboration to bolster RNA-based vaccines in Brazil and beyond | ||
| 02.12.24 | FDA considers 'regulatory action' for bluebird's Skysona after blood cancer reports | ||
| 02.12.24 | Sanofi charts biggest China investment to date with plans for €1B insulin 'manufacturing base' in Beijing | ||
| 02.12.24 | GSK takes AMR message to Paddington, bearing responsibility for raising awareness of risks | ||
| 02.12.24 | Race is on for oral obesity drugs with multiple phase 3 trials vying for next-gen status in a $126B market | ||
| 27.11.24 | FDA oncology advisory committee to weigh Exelixis' Cabometyx in neuroendocrine tumors | ||
| 27.11.24 | Sanofi opens $590M modular vaccine, biologics plant in Singapore | ||
| 27.11.24 | Kelun's Merck-partnered ADC snags first nod in China to kick off TROP2 fight with Gilead | ||
| 27.11.24 | With narcolepsy trial win, Axsome looks to revive former Pfizer antidepressant on the US market | ||
| 27.11.24 | Most life sciences CEOs expect to grow their head counts over the next 3 years: KPMG survey | ||
| 26.11.24 | Novartis plots more than 100 layoffs in New Jersey as part of rework to Xolair, cancer combo field sales teams | ||
| 26.11.24 | Portuguese CDMO Hovione completes factory expansions in US, Ireland | ||
| 26.11.24 | Shorla gains FDA nod for first oral liquid version of Novartis' Gleevec | ||
| 26.11.24 | Guardant awarded $293M in false advertising case against fellow cancer test maker Natera | ||
| 26.11.24 | Fast-growing Adragos snaps up Swiss CDMO Baccinex, significantly expanding fill-finish firepower | ||
| 25.11.24 | ASH: Incyte's Monjuvi triumphs in follicular lymphoma phase 3, teeing up FDA filing | ||
| 25.11.24 | India's Lupin recalls more than 600K bottles of blood pressure med over questionable API source |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
